iShares Exponential Technologies ETF (XT)
Look-through valuation · Theme · Expense ratio 0.46 % · ISIN US46434V3814
Price history (since 2015)
Monthly close since 2015. Price shows performance, the valuation verdict is in the look-through above.
Top holdings
| Holding | Weight | vs fair value | Quality |
|---|---|---|---|
| Texas Instruments Incorporated TXN | 4.1 % | −79.3 % | 70 |
| NVIDIA Corporation NVDA | 4.0 % | −54.4 % | 68 |
| Eli Lilly and Company LLY | 4.0 % | −65.7 % | 73 |
| Tesla Inc TSLA | 3.8 % | −80.0 % | 37 |
| Johnson & Johnson JNJ | 3.3 % | −31.6 % | 84 |
| Microsoft Corporation MSFT | 3.2 % | −30.7 % | 59 |
| Analog Devices Inc ADI | 3.1 % | −76.2 % | 79 |
| Palo Alto Networks Inc PANW | 2.8 % | −80.0 % | 66 |
| Amazon.com Inc AMZN | 2.8 % | −49.9 % | 53 |
| AbbVie Inc ABBV | 2.3 % | −72.3 % | 75 |
| Alphabet Inc Class A GOOGL | 2.3 % | n/a | n/a |
| Crowdstrike Holdings Inc CRWD | 2.1 % | −80.0 % | 58 |
| Broadcom Inc AVGO | 2.1 % | −78.8 % | 67 |
| Taiwan Semiconductor Manufacturing Co. Ltd. 2330 | 2.0 % | −46.4 % | 78 |
| Murata Mfg Co 6981 | 1.8 % | n/a | n/a |
| Infineon Technologies AG IFX | 1.8 % | −78.7 % | 61 |
| Novartis AG NOVN | 1.6 % | +19.0 % | 83 |
| Meta Platforms Inc. META | 1.6 % | −21.5 % | 60 |
| Roche Holding AG ROP | 1.6 % | +8.2 % | 75 |
| Merck & Company Inc MRK | 1.6 % | +3.2 % | 74 |
| AstraZeneca PLC AZN | 1.4 % | n/a | n/a |
| Intuitive Surgical Inc ISRG | 1.3 % | −62.7 % | 57 |
| S&P Global Inc SPGI | 1.2 % | −55.8 % | 67 |
| Cisco Systems Inc CSCO | 1.2 % | −61.5 % | 77 |
| Micron Technology Inc MU | 1.2 % | −80.0 % | 73 |
Fair value and quality per position come from the same valuation as our stock pages. Showing the 25 largest of 193 disclosed positions. "n/a" means the position is not (yet) in our stock universe and does not enter the average.
How the look-through works
An ETF has no fair value of its own like a single stock. We build it bottom up: every holding has a fair value and a quality score on our pages. Weighted by portfolio share, that gives iShares Exponential Technologies ETF an average of how cheap or expensive its companies currently sit versus fair value, and how high their average quality is.
As of: Jul 17, 2026
No investment advice, no buy or sell recommendation. The look-through is a computed summary of public fundamentals and is no substitute for your own research.